期刊文献+

去甲肾上腺素预处理对缺血/再灌注大鼠心脏超微结构、心功能的保护作用 被引量:5

The protective effect of NEPC on the ultra-structure and cardiac function of ischemic/reperfused rat heart
下载PDF
导出
摘要 目的 观察比较外源性微量去甲肾上腺素预处理及经典缺血预处理对在体大鼠缺血 /再灌注心脏损伤的保护效应。方法 将实验动物分为假手术组、缺血 /再灌注组、经典缺血预处理和去甲肾上腺素预处理等 4组。再灌结束后 ,分别测定心功能、心肌丙二醛含量 ,观察心肌超微结构、过氧化氢酶损伤性反应。结果 经典缺血预处理和去甲肾上腺素预处理均能改善心功能、保护心肌超微结构、保护心肌过氧化氢酶活性。结论 外源性去甲肾上腺素预处理是一种无明显创伤性的对缺血 /再灌注大鼠心脏具保护作用的预处理方法 ,能模拟经典缺血预处理心脏保护效应。 AIM To compare the protective effects of norepinephrine preconditioning(NEPC)and ischemic preconditioning(IPC)on myocardial ischemic/reperfused injury in rats in vivo . METHODS Rats were divided into control, ischemia/ reperfusion, classic IPC and NEPC groups. After 20 min reperfusion, several indexes including cardiac function indexes, MDA were tested, the myocardial ultrastr ucture and the injury reaction of catalase observed. RESULTS Both IPC and NEPC could protect myocardial ultra structure, ameliorate left heart function, decrease cardiac MDA content and protect the activity of catalase. CONCLUSION Extra micro norepinephrine preconditioning as a non injury method can mimic the protective effects of classic IPC and shows its clinical values.
出处 《中国药理学通报》 CAS CSCD 北大核心 2000年第6期699-702,共4页 Chinese Pharmacological Bulletin
基金 湖北省自然科学基金资助课题.No95J31
关键词 缺血预处理 去甲肾上腺素 大鼠 心脏 缺血/再灌注 ischemic preconditioning norepinephrine rat heart ischemia/reperfusion
  • 相关文献

参考文献1

共引文献2

同被引文献30

  • 1杨进城,季锡清,李朝龙,林建华,刘兴国.肝缺血再灌注损伤早期对其他脏器的影响[J].第一军医大学学报,2004,24(9):1019-1022. 被引量:11
  • 2Zuo-lin FU,Yi-bai FENG,Hong-xia XU,Xin-ping ZHANG,Chun-zhi SHI,Xiang GU.Role of norepinephrine in development of short-term myocardial hibernation[J].Acta Pharmacologica Sinica,2006,27(2):158-164. 被引量:7
  • 3Guo Z,Yao TP,Wang JP,et al.Acute myocardial ischemia upregulates nociceptin/orphanin FQ in dorsal root ganglion and spinal cord of rats.Neurosci Lett,2008,433(3):274-278.
  • 4Schomig A.Catecholamines in myocardial ischemia:Systemic and cardiac release.Circulation,1990,82(3 Suppl):Ⅱ13-Ⅱ22.
  • 5Kapusta DR,Burmeister MA,Calo'G,et al.Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.J Pharmacol Exp Ther,2005,314(2):643-651.
  • 6Salis MB,Emanueli C,Milia AF,et al.Studies of the cardiovascular effects of nociceptin and related peptides.Petides 2000,21(7):985-993.
  • 7Nothacker HP,Reinscheid RK,Mansour A,et al.Primary structure and tissue distribution of the orphanin FQ precursor.Proc Natl Acad Sci U S A,1996,93(16):8677-8682.
  • 8McDonald J,Barnes TA,Okawa H,et al.Partial agonist behaviour depeMs upon the level of nociceptin/orphanin FQ receptor expression:studies using the ecdysone-inducible mammalian expression system.Br J Pharmacol,2003;140(1):61-70.
  • 9Bucher B.ORL1 receptor-mediated inhibition by nociceptin of norad-renaline release from perivascular sympathetic nerve endings of the rat tail artery.Nannyn Schmiedebergs Arch Pharmacol,1998,358(6):682-685.
  • 10Przydzial MJ,Heisler LK.Nociceptin/orphanin FQ peptide receptor as a therapeutic target for obesity.Mini Rev Med Chem,2008,8(8):796-811.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部